Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

7 $

Format : Publisher PDF

File Size : 9 MB

Category:

Drug Development for Rare Diseases (Chapman & Hall/CRC Biostatistics Series)

By Bo Yang, Yang Song, Yijie Zhou

By Bo Yang, Yang Song, Yijie Zhou

Rare Disease Drug Development: Challenges and Strategies

A disease is defined as rare if the prevalence is fewer than 200,000 in the United States. It is estimated that there are more than 7,000 rare diseases, which collectively affect 30 million Americans or 10% of the US population. This diverse and complex disease area poses challenges for patients, caregivers, regulators, drug developers, and other stakeholders.

Rare Disease Drug Development: Challenges and Strategies provides an comprehensive overview of the common issues facing rare disease drug developers. It delves into the challenges specific to clinical development in small populations, discusses innovative drug development strategies in the evolving regulatory environment, and explores the generation and utilization of different data and evidence inside and beyond clinical trials. By using recent examples, the authors demonstrate these challenges and the development strategies that respond to them.

About the Authors

The authors of Rare Disease Drug Development: Challenges and Strategies are Bo Yang, Yang Song, and Yijie Zhou, experts in the field of rare disease drug development. They bring a wealth of knowledge and experience to the book, ensuring that readers gain valuable insights into this complex and important area of healthcare.

Key Features

Rare Disease Drug Development: Challenges and Strategies covers a range of topics related to rare diseases and drug development:

  • Rare disease overview: Gain an understanding of the prevalence and impact of rare diseases in the United States.
  • Clinical development challenges: Explore the unique challenges that arise when developing drugs for small patient populations.
  • Innovative trial design: Learn about innovative clinical trial designs that can overcome the challenges of developing drugs for rare diseases.
  • Regulatory approval: Understand the evolving regulatory landscape and the strategies necessary for gaining approval for rare disease drugs.
  • Real-world evidence: Discover the importance of real-world evidence in rare disease drug development and how it can be generated and utilized.

Why Should You Read “Rare Disease Drug Development: Challenges and Strategies”?

Rare diseases are often overlooked and underrepresented in the field of drug development. However, they affect millions of people and present unique challenges to researchers, regulators, and drug developers. By reading Rare Disease Drug Development: Challenges and Strategies, you will gain a comprehensive understanding of the issues involved in developing drugs for rare diseases and the strategies that can be employed to overcome these challenges.

Whether you are a patient, caregiver, healthcare professional, regulator, or drug developer, this book will provide you with valuable insights and knowledge to navigate the complex landscape of rare disease drug development. It offers a multidimensional view of the subject, combining scientific, regulatory, and practical perspectives to give you a holistic understanding of the field.

Order “Rare Disease Drug Development: Challenges and Strategies” Today

Don’t miss out on the opportunity to gain valuable insights into the challenges and strategies of rare disease drug development. Order your copy of Rare Disease Drug Development: Challenges and Strategies today and equip yourself with the knowledge to make a difference in this important field.

Product Details

  • Publisher ‏ : ‎ Chapman and Hall/CRC; 1st edition (February 13, 2023)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 222 pages
  • ISBN-10 ‏ : ‎ 0367518341
  • ISBN-13 ‏ : ‎ 978-0367518349

Related Products